ARCA biopharma Inc.

NASDAQ: ABIO · Real-Time Price · USD
28.80
26.30 (1052.00%)
At close: Aug 30, 2024, 10:00 PM

ARCA biopharma Revenue

ARCA biopharma reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, ARCA biopharma generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
3
Market Cap
34.82M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a
Dec 31, 2021 0 n/a
Dec 31, 2020 0 n/a
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Dec 31, 2011 0 n/a
Dec 31, 2010 0 n/a
Dec 31, 2009 0 -100.00%
Dec 31, 2008 15.25M -67.45%
Dec 31, 2007 46.86M +1105.27%
Dec 31, 2006 3.89M +613.39%
Dec 31, 2005 545K +179.49%
Dec 31, 2004 195K -91.48%
Dec 31, 2003 2.29M -91.34%
Dec 31, 2002 26.43M +7.49%
Dec 31, 2001 24.59M +57.59%
Dec 31, 2000 15.6M +143.81%
Dec 31, 1999 6.4M -33.33%
Dec 31, 1998 9.6M +54.84%
Dec 31, 1997 6.2M +1450.00%
Dec 31, 1996 400K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.